Cargando…

PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma

Viral hepatitis with hepatitis C virus or hepatitis B virus and chronic liver disease such as alcoholic or nonalcoholic steatohepatitis are critical factors in the development of hepatocellular carcinoma (HCC). Furthermore, diabetes is known as an independent risk factor for HCC. Peroxisome prolifer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, Osamu, Kondo, Yasuteru, Shimosegawa, Tooru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533465/ https://www.ncbi.nlm.nih.gov/pubmed/23316217 http://dx.doi.org/10.1155/2012/574180

Ejemplares similares

Hepatitis B Surface Antigen Could Contribute to the Immunopathogenesis of Hepatitis B Virus Infection
por: Kondo, Yasuteru, et al.
Publicado: (2013)

Toll-Like Receptors Signaling Contributes to Immunopathogenesis of HBV Infection
por: Kondo, Yasuteru, et al.
Publicado: (2011)

Expression of EpCAM Increases in the Hepatitis B Related and the Treatment-Resistant Hepatocellular Carcinoma
por: Kimura, Osamu, et al.
Publicado: (2014)

HCV Infection Enhances Th17 Commitment, Which Could Affect the Pathogenesis of Autoimmune Diseases
por: Kondo, Yasuteru, et al.
Publicado: (2014)

Significant Roles of Regulatory T Cells and Myeloid Derived Suppressor Cells in Hepatitis B Virus Persistent Infection and Hepatitis B Virus-Related HCCs
por: Kondo, Yasuteru, et al.
Publicado: (2015)

Biological Significance of HCV in Various Kinds of Lymphoid Cells
por: Kondo, Yasuteru, et al.
Publicado: (2012)

The Relationship between Renal Dysfunction and Abnormalities of the Immune System in Patients with Decompensated Cirrhosis
por: Kakazu, Eiji, et al.
Publicado: (2012)

Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis
por: Ninomiya, Masashi, et al.
Publicado: (2012)

Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT
por: Kondo, Yasuteru, et al.
Publicado: (2011)

Plasma amino acids imbalance in cirrhotic patients disturbs the tricarboxylic acid cycle of dendritic cell
por: Kakazu, Eiji, et al.
Publicado: (2013)

PD-L1(+)MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment
por: Iwata, Tomoaki, et al.
Publicado: (2016)

Plasma L-Cystine/L-Glutamate Imbalance Increases Tumor Necrosis Factor-Alpha from CD14+ Circulating Monocytes in Patients with Advanced Cirrhosis
por: Kakazu, Eiji, et al.
Publicado: (2011)

Distinct MicroRNAs Expression Profile in Primary Biliary Cirrhosis and Evaluation of miR 505-3p and miR197-3p as Novel Biomarkers
por: Ninomiya, Masashi, et al.
Publicado: (2013)

PPARs and Liver Disease
por: Kondo, Yasuteru, et al.
Publicado: (2013)

The Role of PPARγ in Hepatocellular Carcinoma
por: Borbath, Ivan, et al.
Publicado: (2008)

Pathogenesis to management of hepatocellular carcinoma
por: Da, Ben L., et al.
Publicado: (2022)

Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping
por: Kakuta, Yoichi, et al.
Publicado: (2017)

PBC: Animal Models of Cholangiopathies and Possible Endogenous Viral Infections
por: Ninomiya, Masashi, et al.
Publicado: (2012)

Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

The reduction of miR146b-5p in monocytes and T cells could contribute to the immunopathogenesis of hepatitis C virus infection
por: Kondo, Yasuteru, et al.
Publicado: (2019)

Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
por: Cucarull, Blanca, et al.
Publicado: (2022)

The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma
por: Damaskos, Christos, et al.
Publicado: (2022)

Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
por: Tümen, Deniz, et al.
Publicado: (2022)

Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
por: Kouroumalis, Elias, et al.
Publicado: (2023)

Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy
por: Luo, Wenyu, et al.
Publicado: (2022)

Alpha-1-Antitrypsin in Pathogenesis of Hepatocellular Carcinoma
por: Topic, Aleksandra, et al.
Publicado: (2012)

The Molecular Pathogenesis and Clinical Implications of Hepatocellular Carcinoma
por: Meguro, Makoto, et al.
Publicado: (2011)

1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial
por: Kondo, Yasuteru, et al.
Publicado: (2013)

Immune Pathogenesis of Hepatocellular Carcinoma
por: Nakamoto, Yasunari, et al.
Publicado: (1998)

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances
por: Dhanasekaran, Renumathy, et al.
Publicado: (2016)

MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review
por: Morishita, Asahiro, et al.
Publicado: (2021)

Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
por: García-Pras, Ester, et al.
Publicado: (2021)

Role of p53 suppression in the pathogenesis of hepatocellular carcinoma
por: Choudhary, Heena B, et al.
Publicado: (2023)

Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma
por: Nevola, Riccardo, et al.
Publicado: (2023)

MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma
por: Zeng, Ju-deng, et al.
Publicado: (2018)

Ubiquitin-specific protease 22 promotes lipogenesis contributing to Hepatocellular Carcinoma pathogenesis
por: Xu, Yanyan, et al.
Publicado: (2022)

Notch1 directly induced CD133 expression in human diffuse type gastric cancers
por: Konishi, Hidetomo, et al.
Publicado: (2016)

Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma?
por: Lee, Choong-kun, et al.
Publicado: (2022)

Could an Impairment in Local Translation of mRNAs in Glia be Contributing to Pathogenesis in ALS?
por: Barton, Samantha K., et al.
Publicado: (2019)

NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
por: Mackenzie, Gerardo G., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rmqf79mbg96hhl0jfb9io3vvnk